Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

Zhendong Pharmaceutical announced results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb trial of its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use. The provided article text does not disclose efficacy, safety, endpoint, or regulatory details, limiting assessment of the trial's commercial significance.